At meeting held on 10 January 2023
The Board of Medplus Health Services at its meeting held on 10 January 2023 approved the Scheme of Amalgamation (Scheme) under Section 230 to Section 232 and other relevant provisions of the Companies Act, 2013 for amalgamation between MedPlus Health Services Limited (Transferee Company) and MHS Pharmaceuticals Private Limited (Transferor Company), subject to requisite approvals. The Transferor Company is the wholly owned subsidiary of the Transferee Company.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
